Domov › Rak pljuč › Virginia › Arlington
Klinične študije za Rak pljuč v Arlington, VA
41 študij za Rak pljuč išče udeležence na lokacijah v Arlington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Vključevanje udeležencevFaza 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi stran
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Vključevanje udeležencevFaza 2
- Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · 11 mi stran
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of PHN-012 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- PHN-012-001 Site, Fairfax · 11 mi stran
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 mi stran
- Inova Schar Cancer, Fairfax · 11 mi stran
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- Research Site, Fairfax · 11 mi stran
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Vključevanje udeležencevFaza 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi stran
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Vključevanje udeležencevFaza 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi stran
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT - Virginia, Fairfax · 11 mi stran
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi stran
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Vključevanje udeležencevFaza 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi stran
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 1
- NEXT Oncology, Fairfax · 11 mi stran
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- Inova Fair Oaks Hospital, Fairfax · 11 mi stran
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Vključevanje udeležencevFaza 3
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- Inova Fair Oaks Hospital, Fairfax · 11 mi stran
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi stran
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Vključevanje udeležencevFaza 1
- Research Site, Fairfax · 11 mi stran
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi stran
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi stran
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Vključevanje udeležencevFaza 1/2
- Next Oncology Virginia, Fairfax · 11 mi stran
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Vključevanje udeležencevFaza 1/2
- NEXT Oncology, Fairfax · 11 mi stran
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi stran
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi stran
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Vključevanje udeležencevFaza 2
- Inova Fairfax Hospital, Fairfax · 11 mi stran
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Študije za Rak pljuč v drugih mestih
- Houston, TX78 študij
- Boston, MA62 študij
- New York City, NY60 študij
- Los Angeles, CA45 študij
- Washington, DC41 študij
- Chicago, IL41 študij
- Nashville, TN40 študij
- Baltimore, MD40 študij
- St. Louis, MO39 študij
- Columbus, OH37 študij
- Philadelphia, PA36 študij
- Seattle, WA33 študij
Druge študije v Arlington
- Nemalicelični pljučni rak104 študij
- Metastatski rak53 študij
- Kolorektalni rak52 študij
- Rak (vse vrste)48 študij
- Rak dojke46 študij
- Rak jajčnikov46 študij
- Rak endometrija39 študij
- Rak trebušne slinavke33 študij
- Ploščatocelični karcinom glave in vratu26 študij
- Mikrocitni rak pljuč23 študij
- Trojno negativni rak dojke20 študij
- Rak želodca20 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.